#GLP-1
10 articles
Is the Weight Lost Fat or Muscle? Four Separate Questions — Two Answered, One Not
Both studies measured only what a scale and an X-ray scan can see[F1][F3]. Strength, walking speed, falls — none of thes…
#瘦瘦針#GLP-1#體組成#瘦體重#肌少症#DXA#證據解讀#健康的真實
Can GLP-1 Weight-Loss Trials Be Applied Directly to People in Taiwan? Taiwanese Sites Enrolled, Still No Taiwanese Subgroup Data
Taiwan does appear among the enrolment sites of three global trials, but "Taiwanese sites enrolled" and "a published Tai…
#瘦瘦針#GLP-1#亞洲證據#台灣#tirzepatide#semaglutide#SURMOUNT-CN#STEP 6#外推#健康的真實
Side Effects Cannot Be Flattened Into One List: Settled Warnings, Monitoring Signals, and Regulators Out of Step
The same safety term can carry four different statuses at once: in a regulatory conclusion, in a manufacturer's current …
#瘦瘦針#GLP-1#副作用#FDA#EMA#藥品標示#自殺意念#NAION#藥物安全#健康的真實
What Happens to Body Weight After Stopping: Why You Keep Meeting Three Numbers That Seem to Contradict Each Other
None of the three numbers is wrong[F1][F6][F11]. They contradict each other because, in the course of being copied from …
#瘦瘦針#GLP-1#停藥#體重回升#臨床試驗#證據解讀#健康的真實
The Statutory Ledger for These Drugs in Taiwan: Which Licences Are Live, Which Left Long Ago, and Where the Names Go Wrong
The easiest thing to get wrong comes first: the name many people remember cannot be found in the regulator's data at all…
#瘦瘦針#GLP-1#減重藥#藥品許可證#台灣法規#健康的真實
How Many Pitfalls Lie Between You and Checking a Drug: Nine Failures That Produce Normal-Looking Output, Each With a Rerunnable Verification
A failure that raises an error is not the dangerous kind — you will notice that one. The dangerous kind is a query that …
#瘦瘦針#GLP-1#查證方法#開放資料#文獻檢索#正負控制#資料品質#健康的真實
Not Just Weight Loss: Taiwan's Approved Indications Already Reach the Heart, the Liver, and Sleep
The same active ingredient, in different brands, can have indications that differ so far that one says weight control an…
#瘦瘦針#GLP-1#適應症#藥品許可證#心血管#脂肪肝#睡眠呼吸中止#台灣法規#健康的真實
Have Mounjaro and Wegovy Actually Been Compared Head to Head? The 72-Week Numbers, What They Support, and Where They Stop
−20.2% versus −13.7% is a clear answer about a weight endpoint. It is not a verdict on every health outcome for either d…
#瘦瘦針#GLP-1#tirzepatide#semaglutide#猛健樂#週纖達#SURMOUNT-5#隨機試驗#證據邊界#健康的真實
Buying These Drugs Online and Drawing Up Your Own Doses: What the FDA and EMA Have Actually Found
What regulators have found is not one single kind of "fake drug": there are counterfeit finished products, compounded la…
#瘦瘦針#GLP-1#偽藥#網購藥品#compounded#semaglutide#tirzepatide#FDA#EMA#藥品供應鏈#健康的真實
Where the Literature Went Five Years After Professor Lin Wrote About These Drugs: An Update Line That Can Be Checked Sentence by Sentence
Any article can only cite the literature that existed on the day it was published. Looking back from February 2021 to Ja…
#瘦瘦針#GLP-1#林慶順#文獻更新#證據時序#EMA#FDA#健康的真實